← All news

FROM THE NEWS FEED

Enveric Biosciences Welcomes Final FDA Guidance for Psychedelic Drug Development

2026-07-28 • Psychedelic Invest

Article summary

CAMBRIDGE, Mass., July 28, 2026--Enveric Biosciences (NASDAQ: ENVB) ("Enveric" or the "Company"), a biotechnology company advancing novel neuroplastogenic small-molecule therapeutics to address…

Continue to the original publication for the complete article.